The Use of Ozenoxacin in Pediatric Patients: Clinical Evidence, Efficacy and Safety
Impetigo is the most common childhood skin infection in the world. There are two patterns of impetigo: nonbullous (or impetigo contagiosa) and bullous. The nonbullous type is due to Staphylococcus aureus and group A beta-haemolytic Streptococcus and occurs in 70% of impetigo cases. Impetigo is often...
Saved in:
Main Authors: | Giusy Davino (Author), Tiziana D'Alvano (Author), Susanna Esposito (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo
by: Adelaide A. Hebert, MD, et al.
Published: (2020) -
New therapeutic applications of ozenoxacin in superficial skin infections
by: Gema García Ron, et al.
Published: (2021) -
Green Nail Syndrome Treated with Ozenoxacin: Two Case Reports
by: Terenzio Cosio, et al.
Published: (2023) -
Retrospective Analysis of the Real-World Use of Topical Antimicrobials in the Paediatric Population with Impetigo in Italy: Focus on the Role of Ozenoxacin 1% Cream
by: Elisa Barbieri, et al.
Published: (2023) -
The Evidence Base on the Efficacy and Safety of Ibuprofen in Pediatrics
by: Yu.V. Marushko, et al.
Published: (2013)